Lejeune F - Search Results

1

Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial.

Djeridane M, Oudard S, Escoffre-Barbe M, Lacotte-Thierry L, Desablens B, Briére J, Dib M, Cassasus P, Ghandour C, Lamy T, Lejeune F, Simon M, Traullé C, Vigier M, Maisonneuve H, Briére J, Colonna P, Andrieu JM. Djeridane M, et al. Among authors: lejeune f. Cancer. 2002 Nov 15;95(10):2169-79. doi: 10.1002/cncr.10932. Cancer. 2002. PMID: 12412171 Free article. Clinical Trial.

2

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Mourad N, Mounier N, Brière J, Raffoux E, Delmer A, Feller A, Meijer CJ, Emile JF, Bouabdallah R, Bosly A, Diebold J, Haioun C, Coiffier B, Gisselbrecht C, Gaulard P; Groupe d'Etude des Lymphomes de l'Adulte. Mourad N, et al. Blood. 2008 May 1;111(9):4463-70. doi: 10.1182/blood-2007-08-105759. Epub 2008 Feb 21. Blood. 2008. PMID: 18292286 Free PMC article. Clinical Trial.

3

Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".

Najean Y, Rain JD, Dresch C, Goguel A, Lejeune F, Echard M, Grange MJ. Najean Y, et al. Among authors: lejeune f. Leuk Lymphoma. 1996 Sep;22 Suppl 1:111-9. doi: 10.3109/10428199609074368. Leuk Lymphoma. 1996. PMID: 8951781 Review.

4

Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.

Eclache V, Caulet-Maugendre S, Poirel HA, Djemai M, Robert J, Lejeune F, Raphaël M. Eclache V, et al. Among authors: lejeune f. Cancer Genet Cytogenet. 2004 Jul 1;152(1):72-6. doi: 10.1016/j.cancergencyto.2003.10.010. Cancer Genet Cytogenet. 2004. PMID: 15193446

5

[Treatment of polycythemia. II.--Comparison of hydroxyurea with pipobroman in 294 patients less than 65 years of age].

Najean Y, Rain JD, Lejeune F, Echard M, Fermand JP, Gruyer P, Brahimi S. Najean Y, et al. Among authors: lejeune f. Ann Med Interne (Paris). 1998 Mar;149(2):94-100. Ann Med Interne (Paris). 1998. PMID: 11490531 Clinical Trial. French.

6

Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine.

Tchernia G, Lejeune F, Boccara JF, Denavit MF, Dommergues JP, Bernaudin F. Tchernia G, et al. Among authors: lejeune f. J Pediatr Hematol Oncol. 1996 Feb;18(1):59-62. doi: 10.1097/00043426-199602000-00011. J Pediatr Hematol Oncol. 1996. PMID: 8556372

7

Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen.

Beguin Y, Loo M, R'Zik S, Sautois B, Lejeune F, Rorive G, Fillet G. Beguin Y, et al. Among authors: lejeune f. Blood. 1993 Oct 1;82(7):2010-6. Blood. 1993. PMID: 8400253 Free article.

8

Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters.

Beguin Y, Loo M, R'Zik S, Sautois B, Lejeune F, Rorive G, Fillet G. Beguin Y, et al. Among authors: lejeune f. Eur J Haematol. 1994 Nov;53(5):265-70. doi: 10.1111/j.1600-0609.1994.tb01318.x. Eur J Haematol. 1994. PMID: 7813706

9

Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin.

Beguin Y, Loo M, R'Zik S, Sautois B, Lejeune F, Rorive G, Fillet G. Beguin Y, et al. Among authors: lejeune f. Br J Haematol. 1995 Jan;89(1):17-23. doi: 10.1111/j.1365-2141.1995.tb08916.x. Br J Haematol. 1995. PMID: 7833259

10

Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.

Gobert A, Brocco M, Dekeyne A, Di Cara B, Bouchez G, Lejeune F, Gannon RL, Millan MJ. Gobert A, et al. Among authors: lejeune f. Neuropsychopharmacology. 2009 Mar;34(4):1039-56. doi: 10.1038/npp.2008.176. Epub 2008 Oct 1. Neuropsychopharmacology. 2009. PMID: 18830239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

547 results

Search Page